Attention Deficit Clinical Trials
2 recruiting trials for Attention Deficit. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Attention Deficit clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Children's National Research Institute (1), Francisco Gonzalez-Lima, PhD (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is EndeavorRx (device, 1 trial), followed by Transcranial photobiomodulation, Sham transcranial photobiomodulation.
Track Attention Deficit trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease
Children with sickle cell disease (SCD) exhibit significantly reduced cognitive functioning (often difficulties with attention) compared to peers and siblings without SCD....
Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation
Inattentiveness and impulsivity in healthy adults and individuals with attention deficit hyperactivity disorder (ADHD) diminish these individuals' quality of life. Cortical...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Attention Deficit, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Attention Deficit, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Attention Deficit, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.